Kawamata H - Search Results

1

Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.

Nakashiro K, Kawamata H, Hino S, Uchida D, Miwa Y, Hamano H, Omotehara F, Yoshida H, Sato M. Nakashiro K, et al. Among authors: kawamata h. Cancer Res. 1998 Feb 1;58(3):549-55. Cancer Res. 1998. PMID: 9458104

2

Effects of retinoic acid on morphological features and biological markers of a neoplastic human salivary intercalated duct cell line in culture.

Azuma M, Kawamata H, Kasai Y, Nagamine S, Yoshida H, Yanagawa T, Sato M. Azuma M, et al. Among authors: kawamata h. Cancer Res. 1988 Dec 15;48(24 Pt 1):7219-25. Cancer Res. 1988. PMID: 2461255

3

Induction of cells with a chondrocyte-like phenotype by treatment with 1 alpha,25-dihydroxyvitamin D3 in a human salivary acinar cell line.

Azuma M, Kawamata H, Kasai Y, Yanagawa T, Yoshida H, Sato M. Azuma M, et al. Among authors: kawamata h. Cancer Res. 1989 Oct 1;49(19):5435-42. Cancer Res. 1989. PMID: 2670204

4

Cellular proliferation and ras oncogene of p21 21,000 expression in relation to the intracellular cyclic adenosine 3':5'-monophosphate levels of a human salivary gland adenocarcinoma cell line in culture.

Azuma M, Yoshida H, Kawamata H, Yanagawa T, Furumoto N, Sato M. Azuma M, et al. Among authors: kawamata h. Cancer Res. 1988 May 15;48(10):2898-903. Cancer Res. 1988. PMID: 2834050

5

Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.

Kawamata H, Nakashiro K, Uchida D, Harada K, Yoshida H, Sato M. Kawamata H, et al. Int J Cancer. 1997 Jan 6;70(1):120-7. doi: 10.1002/(sici)1097-0215(19970106)70:1<120::aid-ijc18>3.0.co;2-p. Int J Cancer. 1997. PMID: 8985100

6

Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene.

Sato M, Kawamata H, Harada K, Nakashiro K, Ikeda Y, Gohda H, Yoshida H, Nishida T, Ono K, Kinoshita M, Adachi M. Sato M, et al. Among authors: kawamata h. Cancer Lett. 1997 Jan 30;112(2):181-9. doi: 10.1016/s0304-3835(96)04581-8. Cancer Lett. 1997. PMID: 9066726

7

Emergence of osteoblast-like cells in a neoplastic human salivary cancer cell line after treatment with 22-oxa-1alpha, 25-dihydroxyvitamin D3.

Sato M, Iga H, Yoshioka N, Fukui K, Kawamata H, Yoshida H, Hirota S, Kitamura Y. Sato M, et al. Among authors: kawamata h. Cancer Lett. 1997 May 19;115(2):149-60. doi: 10.1016/s0304-3835(97)04722-8. Cancer Lett. 1997. PMID: 9149118

8

Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.

Kawamata H, Nakashiro K, Uchida D, Hino S, Omotehara F, Yoshida H, Sato M. Kawamata H, et al. Br J Cancer. 1998;77(1):71-8. doi: 10.1038/bjc.1998.11. Br J Cancer. 1998. PMID: 9459148 Free PMC article.

9

Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients.

Kawamata H, Uchida D, Nakashiro K, Hino S, Omotehara F, Yoshida H, Sato M. Kawamata H, et al. Br J Cancer. 1999 May;80(3-4):448-52. doi: 10.1038/sj.bjc.6690377. Br J Cancer. 1999. PMID: 10408852 Free PMC article.

10

Balance between activated-STAT and MAP kinase regulates the growth of human bladder cell lines after treatment with epidermal growth factor.

Kawamata H, Hattori K, Omotehara F, Uchida D, Hino S, Sato M, Oyasu R. Kawamata H, et al. Int J Oncol. 1999 Oct;15(4):661-7. doi: 10.3892/ijo.15.4.661. Int J Oncol. 1999. PMID: 10493946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters